Revolutionary First-in-Class Therapies for Triple Negative Breast Cancer

Science

We have identified a novel molecular target for Triple Negative Breast Cancer

Therapeutics

We are developing targeted therapies for Triple Negative Breast cancer

Diagnostics

We are developing IVD kits for the detection of Triple Negative Breast Cancer